Clinical TrialID 3558
Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy
NCT00510809
High Cholesterol
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 3558
- Evidence Id
- 3558
- Core Evidence Id
- 3558
- Source Clinical Trial Id
- 3532
- Herb2 Clinical Trial Id
- HBCT003532
- Nct Id
- NCT00510809
- Title
- Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy
- Status
- Completed
- Phase
- Study Result
- Yes
- Study Condition
- High Cholesterol
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Policosanol|OTHER: Placebo|DRUG: Policosanol Plus Already In Use Statin Therapy
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 54
- Outcome Measure
- Lipid Profile, Change between Week 8 and Baseline
- Sponsor Collaborator
- James Backes, PharmD|Marcor Development Corporation
- Funded By
- OTHER
- Location
- University of Kansas Medical Center, Kansas City, Kansas, 66160, United States
- Other Id
- QB840230|10494
- Start Date
- 2007-07
- Primary Completion Date
- 2010-03
- Completion Date
- 2010-05
- First Posted
- 2007-08-02
- Results First Posted
- 2012-07-20
- Last Update Posted
- 2015-10-08
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00510809
- Title Cn
- Title En
- Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy
- Bilingual Status
- semi_complete